Flk-1 Monoclonal Antibody

Vascular endothelial growth factor (VEGF) is a major growth factor for endothelial cells. This gene encodes one of the two receptors of the VEGF. This receptor, known as kinase insert domain receptor, is a type III receptor tyrosine kinase. It functions as the main mediator of VEGF-induced endothelial proliferation, survival, migration, tubular morphogenesis and sprouting. The signalling and trafficking of this receptor are regulated by multiple factors, including Rab GTPase, P2Y purine nucleotide receptor, integrin alphaVbeta3, T-cell protein tyrosine phosphatase, etc.. Mutations of this gene are implicated in infantile capillary hemangiomas.

The FLK-1 Monoclonal Antibody is a cutting-edge product that has been meticulously developed to cater to the needs of researchers and scientists in the field of biotechnology. This antibody, derived from a hybridoma cell line, exhibits exceptional specificity and sensitivity, making it an invaluable tool for various applications, including immunohistochemistry, flow cytometry, and Western blotting.

The FLK-1 Monoclonal Antibody is designed to target and bind to the FLK-1 protein, a receptor tyrosine kinase that plays a crucial role in angiogenesis and vasculogenesis. With its high affinity and selectivity, this antibody enables precise detection and analysis of FLK-1 expression in various biological samples, facilitating a deeper understanding of the underlying mechanisms involved in vascular development and related diseases.

This product has undergone rigorous quality control measures to ensure its reliability and reproducibility. Each batch of FLK-1 Monoclonal Antibody is thoroughly tested for specificity, sensitivity, and consistency, guaranteeing consistent and accurate results. Furthermore, it has been validated for use in multiple species, including human, mouse, and rat, broadening its applicability and versatility.

The FLK-1 Monoclonal Antibody is supplied in a convenient and user-friendly format, allowing for easy handling and storage. It is provided in a liquid formulation, eliminating the need for reconstitution, and is packaged in vials with optimal storage conditions to maintain its stability and efficacy.

In summary, the FLK-1 Monoclonal Antibody is an exceptional research tool that offers unparalleled specificity, sensitivity, and reliability. Its broad applicability and user-friendly format make it an indispensable asset for scientists and researchers seeking to unravel the complexities of angiogenesis and vasculogenesis.